Sangamo Announces ASGCT 2024


Sangamo Therapeutics Announces First Quarter 2023 Conference Call and Webcast

BRISBANE, Calif. --(BUSINESS WIRE)--Apr. 19, 2023-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to release its first quarter 2023 financial results after the market closes on Wednesday, April 26, 2023 .